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Diagnostic Dilemma 
 
Answers: 
 
1)  C 
Patient is planned for an elective procedure. He has history of recent placement of a drug eluting stent (DES). 
He is at risk of stent thrombosis with premature discontinuation of dual antiplatelet therapy (DAPT) (<12 
months after placement of a DES). Patient should be counselled to defer surgery until it is safe to discontinue 
clopidogrel. Although data is emerging that it may be safe to stop DAPT early (some trials have shown 3-6 
months of DAPT is safe), until guidelines are updated it may be safe to postpone surgery until he completes at 
least 6 months and possibly even 12 months of DAPT.  
 
2)  C 
Patient does not need any further workup from a cardiac standpoint. Any workup would delay the definitive 
therapy which in the case of a ruptured appendix is emergent surgery.  
 
3)  D 
Patient has a bi-leaflet valve in aortic position which is associated with low risk for thromboembolic events. 
Therapeutic ERCP is a procedure associated with high bleeding risk. He does not have risk factors like stroke, 
TIA or prior embolism which would put him at high risk for thromboembolic events. No bridging is needed in 
this scenario. Mechanical valves in mitral position are associated with high thrombotic risk and will need bridg-
ing with UFH peri-procedurally. It is not advisable to use Vitamin K in patients with mechanical valves.  
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